A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
Citations Over TimeTop 15% of 2008 papers
Abstract
Prostate specific membrane antigen (PSMA) is a validated molecular marker for prostate cancer. A series of glutamate-urea (Glu-urea-X) heterodimeric inhibitors of PSMA were designed and synthesized where X = epsilon-N-(o-I, m-I, p-I, p-Br, o-Cl, m-Cl, p-Cl, p-F, H)-benzyl-Lys and epsilon-(p-I, p-Br, p-Cl, p-F, H)-phenylureido-Lys. The affinities for PSMA were determined by screening in a competitive binding assay. PSMA binding of the benzyllysine series was significantly affected by the nature of the halogen substituent (IC(50) values, Cl < I = Br << F = H) and the ring position of the halogen atom (IC(50) values, p-I < o-I << m-I). The halogen atom had little affect on the binding affinity in the para substituted phenylureido-Lys series. Two lead iodine compounds were radiolabeled with (123)I and (131)I and demonstrated specific PSMA binding on human prostate cancer cells, warranting evaluation as radioligands for the detection, staging, and monitoring of prostate cancer.
Related Papers
- → Substituent active region – a gate for communication of substituent charge with the rest of a molecule: Monosubstituted benzenes(2007)91 cited
- → Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay(2002)63 cited
- → Effect of meta-substituents of phenolic antioxidants—proposal of secondary substituent effect(2002)24 cited
- → Effect of substituent on the UV-Vis spectra: an extension from disubstituted to multi-substituted benzylideneanilines(2016)18 cited
- → Proximity effects in pyridines. Proton chemical shifts in substituted methyl pyridinecarboxylates(1975)18 cited